Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Thursday May 26, 2022
Thursday May 26, 2022
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan.
The experts
- Prof. Lisa Licitra - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Dr Aline Chaves - DOM Oncology Group, Divinópolis, Brazil
- Prof. Joël Guigay - Cancer Center Antoine Lacassagne, Nice, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent grant from the healthcare business of Merck KGaA, Darmstadt. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/treatment-provision-recurrent-metastatic-hnscc/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.